INUS
Straddle Chart

Markets / Mutual funds / Other ETFs

Mutual fundsSIF

DSP Nifty Healthcare ETF - Regular Plan - Growth

NAVs of 6 Nov 2026

DSP Mutual Fund · Index & ETFs fund · Regular plan · Growth

Other ETFsRegular · GrowthRisk: Very High
NAV · 5 Nov 2026
₹16.9780 ▲ 0.70%
DSP Mutual Fund
Fund size₹17.78 crJuly - September 2026
1-month range₹15.54 – 16.98
1 year-88.58%rank 168 of 174
Expense ratio0.00%regular plan, a year
5 years–a year

What the fund does

The Scheme seeks to provide returns that, before expenses, correspond to the total return of the underlying index (Nifty Healthcare TRI), subject to tracking errors. There is no assurance that the investment objective of the Scheme will be achieved.

BenchmarkNifty Healthcare TRI
Launched1 Feb 2024
Fund houseDSP Mutual Fund
Fund managersAnil Ghelanisince 1 Feb 2024Diipesh Shahsince 1 Feb 2024Neha Rathisince 1 May 2026

NAV history

161617 2026-08-112026-08-242026-09-042026-09-182026-10-012026-10-152026-10-29

Returns

1 week
+3.85%avg 4.4%
1 month
+4.43%avg 3.0%
3 months
+0.69%avg -2.5%
6 months
-89.05%avg -1.7%
This year
-88.48%avg -5.2%
1 year
-88.58%avg -2.8% · #168/174

Bars: this plan; the thin mark is the Other ETFs average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+4.0
2025-6.2-7.8+7.8+1.1+0.4+3.8+3.3-3.3-1.4+3.8+2.3-2.6
2026-5.1+7.2-4.5+5.0+3.2+4.9-89.6+1.1-4.8+1.9+2.2

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held2022 lines in all
Top 10 stocks75.8%of the fund
Equity99.9%stocks and equity derivatives
Debt & cash0.1%everything else

Where the money is

Equity 99.9%Cash & others 0.1%Short -0.0%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
81.1%
Healthcare Services
18.8%

Changes since 31 Aug 2026

Share of fund30 Sept 202631 Aug 2026Change
Stocks held99.9%99.9%-0.02
Cash & others0.1%0.1%+0.02
Top 10 stocks75.8%77.3%-1.51
Number of stocks20200
New stocks 2
  • Gland Pharma Limited2.04%
  • Krishna Institute Of Medical Sciences Limited1.76%
Stocks sold off 2
  • Piramal Pharma Limitedwas 1.15%
  • Syngene International Limitedwas 0.65%
Bought more 2
  • Dr. Reddy's Laboratories Limited+0.59
  • Laurus Labs Limited+0.40
Cut back 5
  • Sun Pharmaceutical Industries Limited-1.08
  • Max Healthcare Institute Limited-0.56
  • Fortis Healthcare Limited-0.52
  • Apollo Hospitals Enterprise Limited-0.45
  • Biocon Limited-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 20

HoldingSector / type% of fund
Sun Pharmaceutical Industries Limited
INE044A01036		Pharmaceuticals & Biotechnology16.99%
Divi's Laboratories Limited
INE361B01024		Pharmaceuticals & Biotechnology10.43%
Apollo Hospitals Enterprise Limited
INE437A01024		Healthcare Services7.42%
Laurus Labs Limited
INE947Q01028		Pharmaceuticals & Biotechnology6.81%
Cipla Limited
INE059A01026		Pharmaceuticals & Biotechnology6.69%
Dr. Reddy's Laboratories Limited
INE089A01031		Pharmaceuticals & Biotechnology6.64%
Torrent Pharmaceuticals Limited
INE685A01028		Pharmaceuticals & Biotechnology6.24%
Max Healthcare Institute Limited
INE027H01010		Healthcare Services6.11%
Lupin Limited
INE326A01037		Pharmaceuticals & Biotechnology4.36%
Aurobindo Pharma Limited
INE406A01037		Pharmaceuticals & Biotechnology4.08%
Fortis Healthcare Limited
INE061F01013		Healthcare Services3.54%
Glenmark Pharmaceuticals Limited
INE935A01035		Pharmaceuticals & Biotechnology3.11%
Alkem Laboratories Limited
INE540L01014		Pharmaceuticals & Biotechnology2.75%
Zydus Lifesciences Limited
INE010B01027		Pharmaceuticals & Biotechnology2.54%
Mankind Pharma Limited
INE634S01028		Pharmaceuticals & Biotechnology2.51%
IPCA Laboratories Limited
INE571A01038		Pharmaceuticals & Biotechnology2.36%
Biocon Limited
INE376G01013		Pharmaceuticals & Biotechnology2.28%
Gland Pharma Limited
INE068V01023		Pharmaceuticals & Biotechnology2.04%
Krishna Institute Of Medical Sciences Limited
INE967H01025		Healthcare Services1.76%
Abbott India Limited
INE358A01014		Pharmaceuticals & Biotechnology1.26%

Short positions 1

HoldingSector / type% of fund
Net Receivables/Payables–-0.02%

Debt, money market and cash 1

HoldingSector / type% of fund
TREPS / Reverse Repo Investments–0.10%

From the fund house's monthly portfolio (dspim.com), as on 30 Sept 2026. Percentages are of the fund's net assets. Published about ten days after each month ends.

Risk

Volatility230.3%yearly, from daily NAVs
Worst fall-90.46%2 Jul 2026 → 23 Oct 2026
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 2 Feb 2024).

Where it can invest (limits from the scheme document)

A. Equity and Equity Related Securities of companies constituting Nifty Healthcare Index, the Underlying Index
95–100%
B. Cash and Cash Equivalents
0–5%

The ranges the fund is allowed to hold, not what it holds today.

Fund details

Fund size (average AUM, July - September 2026)₹17.78 cr across all plans
Fund houseDSP Mutual Fund
CategoryIndex & ETFs · Other ETFs
PlanRegular
OptionGrowth
Expense ratio (TER)Direct 0.22% · Regular 0.00% (5 Nov 2026)
Minimum investment₹5,000 · additional ₹5,000
Scheme code (AMFI)152306
ISININF740KA1ZG1
NAV date5 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Top Other ETFs funds (regular plans)

Fund1 year3 years (a year)
ICICI PRUDENTIAL SILVER ETF+27.56%+37.06%
Nippon India Silver ETF+27.25%+36.71%
HDFC Silver ETF+26.95%+36.54%
Motilal Oswal Nasdaq Q50 ETF+31.47%+29.58%
Motilal Oswal Nasdaq 100 ETF+11.67%+26.04%
Nippon India Nifty Pharma ETF+24.05%+23.37%
Motilal Oswal BSE Healthcare ETF+15.06%+23.15%
ICICI Prudential Nifty Healthcare ETF+14.29%+21.67%
DSP Nifty Healthcare ETF-88.58%–

All Other ETFs funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of DSP Nifty Healthcare ETF - Regular Plan - Growth today?

₹16.9780 as of 5 Nov 2026, from AMFI's official NAV data.

What are the returns of DSP Nifty Healthcare ETF - Regular Plan - Growth?

1 year: -88.58%

How does DSP Nifty Healthcare ETF rank in its category?

168 of 174 Other ETFs funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.